Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors

Pharmacological Reviews

Volumn 54, Issue 1, 2002, Pages 43-99

  Boehm, Stefan ^a   Kubista, Helmut ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANION CHANNEL; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ B2 RECEPTOR; CANNABINOID 1 RECEPTOR; CATION CHANNEL; DELTA OPIATE RECEPTOR; DOPAMINE RECEPTOR; ENDOTHELIN RECEPTOR; GLYCINE RECEPTOR; HISTAMINE H3 RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; IMIDAZOLINE RECEPTOR; IONOTROPIC RECEPTOR; KAPPA OPIATE RECEPTOR; METABOTROPIC RECEPTOR; MU OPIATE RECEPTOR; MUSCARINIC RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NICOTINIC RECEPTOR; PROSTANOID RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; SEROTONIN 1 RECEPTOR; SEROTONIN 3 RECEPTOR; SOMATOSTATIN RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; DRUG RECEPTOR BINDING; NERVE ENDING; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

ANIMALS; HUMANS; NEURONS; NEUROTRANSMITTER AGENTS; RECEPTORS, PRESYNAPTIC; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 0036200610     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.54.1.43     Document Type: Review

References (594)

1. Modulation of noradrenaline release from isolated human atrial appendages
2. Interleukin-1 beta and tumor necrosis factor-alpha inhibit the release of [3H]-noradrenaline from isolated human atrial appendages
3. 2+ current inhibition in adult rat sympathetic neurons does not require protein kinase C activation
4. Role of cyclic AMP in stimulation-evoked release of 3H-noradrenaline from rabbit isolated ear artery
5. Actions of γ-aminobutyric acid on sympathetic ganglion cells
6. 2+-stimulated catecholamine release from alpha-toxin-permeabilized PC12 cells: Biochemical evidence for exocytosis and its modulation by protein kinase C and G proteins
7. Exocytosis from permeabilized bovine adrenal chromaffin cells is differently modulated by guanosine 5′-[gamma-thio]triphosphate and guanosine 5′-[beta gamma-imido]triphosphate. Evidence for the involvement of various guanine nucleotide-binding proteins
8. Pharmacology of the neurotransmitter release enhancer linopirdin (DuP 996) and insights into its mechanism of action
9. Subtypes of muscarinic receptors in rat duodenum: A comparison with rabbit vas deferens, rat atria, guinea-pig ileum and gallbladder by using imperialine
10. Subtype classification of the presynaptic alpha-adrenoceptors which regulate [3H]-noradrenaline secretion in guinea-pig isolated urethra
11. Presynaptic alpha 2A-adrenoceptors regulate the 3H-noradrenaline secretion in the guinea-pig urethra
12. Rilmenidine reveals differences in the pharmacological characteristics of prejunctional alpha2-adrenoceptors in the guinea-pig, rat and pig
13. Cultured chick sympathetic neurons: Prostanoid EP1 receptor-mediated facilitation of noradrenaline release
14. 1 receptor-mediated facilitation of noradrenaline release from cultured sympathetic neurons
15. P2 purinoceptors modulating noradrenaline release from sympathetic neurons in culture
16. 3H]-noradrenaline release from cultured chick sympathetic neurons
17. Cultured chick sympathetic neurons: ATP-induced noradrenaline release and its blockade by nicotinic receptor antagonists
18. Cultured chick sympathetic neurons: Modulation of electrically evoked noradrenaline release by P2-purinoceptors
19. Abnormal regulation of the sympathetic nervous system in α2A-adrenergic receptor knockout mice
20. 3H]-muscimol in the rat superior cervical ganglion
21. Release of vasoactive intestinal peptide and neuropeptide Y from canine heart
22. Endogenous opioids may modulate catecholamine secretion during high intensity exercise
23. Role of prejunctional β-adrenocepters in rat cardiac sympathetic neurotransmission
24. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
25. Nonvesicular release of neurotransmitter
26. 2+ signaling takes the local route
27. Are imidazoline receptors involved in sympathetic neurotransmission in rat vas deferens?
28. Effect of isoprostanes on sympathetic neurotransmission in the human isolated iris-ciliary body
29. An intracellular analysis of gamma-aminobutyric-acid-associated ion movements in rat sympathetic neurons
30. International Union of pharmacology. XV. Subtypes of gamma-aminobutyric acid A receptors: Classification on the basis of subunit structure and receptor function
31. Hrs-2 is an ATPase implicated in calcium-regulated secretion
32. Mechanisms mediating pituitary adenylate cyclase-activating polypeptide depolarization of rat sympathetic neurons
33. Parsympathetic excitation of sympathetic innervation after cholinesterase inhibition
34. Neuropeptides in the sympathetic system: Presence, plasticity, modulation and implications
35. Neurotransmitter release at individual sympathetic varicosities, boutons
36. 2+ current and M current in rat sympathetic neurons
37. Determination of activity for nociceptin in the mouse vas deferens
38. Glycine receptors: Heterogeneous and widespread in the mammalian brain
39. Histamine H1 and H3 vasodilator mechanisms in the guinea pig ileum
40. Formation of inositol trisphosphate by muscarinic agonists does not stimulate transmitter release in cultured sympathetic neurons
41. The mechanism of inhibition of 3H-norepinephrine release by norepinephrine in cultured sympathetic neurons
42. Does the release of tritiated noradrenaline accurately reflect the release of endogenous noradrenaline from rat vas deferens nerve terminals?
43. Neuropeptide Y inhibits [3H]noradrenaline release in the rat vas deferens independently of cAMP levels
44. Guanine nucleotide effects on catecholamine secretion from digitonin-permeabilized adrenal chromaffin cells
45. 2+ entry
46. 3H]noradrenaline release from guinea pig ileal myenteric plexus and noradrenergic terminals is modulated by different presynaptic α-2 adrenoceptor subtypes
47. Histamine H(3) receptors mediate inhibition of noradrenaline release from intestinal sympathetic nerves
48. + channels in sympathetic neurons by neuropeptides and other ganglionic transmitters
49. 2-purinoceptor activation
50. ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors
51. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors
52. Glycine receptors in cultured chick sympathetic neurons are excitatory and trigger neurotransmitter release
53. Methoxyverapamil reduction of nicotine-induced catecholamine release involves inhibition of nicotinic acetylcholine receptor currents
54. 2+ channels
55. A somatostatin receptor inhibits noradrenaline release from chick sympathetic neurons through pertussis toxin-sensitive mechanisms: Comparison with the action of alpha 2-adrenoceptors
56. 2-autoreceptors control sympathetic transmitter release
57. Receptors controlling transmitter release from sympathetic neurons in vitro
58. Noradrenaline release from rat sympathetic neurones triggered by activation of B2 bradykinin receptors
59. Electrically evoked noradrenaline release from cultured chick sympathetic neurons: Modulation via presynaptic alpha-adrenoceptors and lack of autoinhibition
60. 2-adrenoceptors in chick sympathetic neurons
61. 2+ current in chick sympathetic neurons
62. UTP- and ATP-triggered transmitter release from rat sympathetic neurons via separate receptors
63. 3H]noradrenaline release from chick sympathetic neurons: Role of cyclic AMP
64. 2-autoreceptors in chick sympathetic neurons
65. 2-autoreceptors modulating transmitter release
66. Two different signaling mechanisms involved in the excitation of rat sympathetic neurons by uridine nucleotides
67. Inhibition by interleukin-1 beta of noradrenaline release in rat spleen: Involvement of lymphocytes, NO and opioid receptors
68. Methoxamine inhibits noradrenaline release through activation of alpha 1- and alpha 2-adrenoceptors in rat isolated kidney: Involvement of purines and prostaglandins
69. Effects of imidazolines on noradrenaline release in rat isolated kidney
70. P2-receptor modulation of noradrenergic neurotransmission in rat kidney
71. Release-regulating presynaptic heterocarriers
72. Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways
73. Identification of endogenous sympathetic neuron pituitary adenylate cyclase-activating polypeptide (PACAP): Depolarization regulates production and secretion through induction of multiple propeptide transcripts
74. In field-stimulated guinea-pig atria an AT1-receptor mediated increase of noradrenaline release by angiotensin II is seen only in the presence of prejunctional autoinhibition
75. Inhibition by VIP and atriopeptin II on the field stimulation evoked release of [3H]noradrenaline in the rat portal vein
76. Beta-adrenoceptor-mediated facilitation of noradrenaline and adenosine 5′-triphosphate release from sympathetic nerve supplying the rat tail artery
77. Inhibition of purinergic transmission by prostaglandin E1 and E2 in the guinea-pig vas deferens: An electrophysiological study
78. 2+ channel blockers on noradrenaline release and purinergic neuroeffector transmission in rat tail artery
79. Inhibition of transmitter release from sympathetic nerve endings by omega-conotoxin
80. 2+ channels in HEK 293 cells
81. Regulation of transmitter release by Unc-13 and its homologues
82. Ionic channels and their regulation by G protein subunits
83. Slow cholinergic excitation: A mechanism for increasing neuronal excitability
84. The output of sympathetic transmitter from the spleen of the cat
85. ORL1 receptor-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery
86. 2-adrenoceptors
87. Role of cyclic AMP in the prejunctional alpha 2-adrenoceptor modulation of noradrenaline release from the rat tail artery
88. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines
89. Adenosine inhibits norepinephrine release in the postischemic rat heart: The mechanism of neuronal stunning
90. Do some nerve cells release more than one transmitter?
91. IV. International union of pharmacology nomenclature of adrenoceptors
92. Somatostatin inhibits the release of noradrenaline induced by electrical stimulation of the rat mesenteric artery
93. The mouse vas deferens: A pharmacological preparation sensitive to nociceptin
94. 2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin
95. Hydrolysis-resistant GTP analogs stimulate catecholamine release from digitonin-permeabilized PC12 cells
96. Muscarinic receptors involved in modulation of noradrenaline release and vasodilatation in guinea pig carotid arteries
97. Acute and chronic losartan administration: Effect on angiotensin II content and modulation of [3H]norepinephrine release from rat interscapular brown adipose tissue
98. International Union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors
99. Cholera toxin induces cyclic AMP-independent degradation of Gsα
100. On the existence of functional angiotensin II receptors on vascular sympathetic nerve terminals in the human forearm
101. 2+ regulates the interaction between synaptotagmin and syntaxin 1
102. 2+)-stimulated secretion by modulating membrane-attached exocytic machinery
103. Phosphorylation of Snapin by Pka modulates its interaction with the SNARE complex
104. Rilmenidine-induced ocular hypotension: Role of imidazoline1 and alpha 2 receptors
105. Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria
106. Modulatory effect of bradykinin on noradrenaline release in isolated atria from normal and B2 knockout transgenic mice
107. Modulation of sympathetic nerve activity by perivascular sensory nerves in the arterioles of the guinea-pig small intestine
108. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein
109. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels
110. 2-adrenoceptors
111. 2+ sensitivity
112. Modulation of neurotransmitter release by opioid mu- and kappa-receptors from adrenergic terminals in the myenteric plexus of the guinea-pig colon: Effect of alpha 2-autoreceptor blockade
113. Tonic modulation of neurotransmitter release in the guinea-pig myenteric plexus: Effect of mu and kappa opioid receptor blockade and of chronic sympathetic denervation
114. 1 muscarinic receptors enhance noradrenaline release in mouse atria by activating protein kinase C
115. Facilitation of noradrenaline release from sympathetic nerves through activation of ACTH receptors, beta-adrenoceptors and angiotensin II receptors
116. Inhibitory prejunctional muscarinic receptors at sympathetic nerves do not operate through a cyclic AMP dependent pathway
117. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites
118. Enhancement of noradrenaline release by angiotensin II and bradykinin in mouse atria: Evidence for cross-talk between Gq/11 protein- and Gi/o protein-coupled receptors
119. Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat
120. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat
121. Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues
122. Response to prejunctional adenosine receptors is dependent on stimulus frequency
123. Atp as a presynaptic modulator
124. Neurotransmitter release mechanisms in autonomic nerve terminals
125. Endothelin and post-ganglionic sympathetic neurons
126. 3B subunit is a major determinant of serotonin-receptor function
127. 2+ and assembly with the core SNARE complex onto membranes
128. International Union of pharmacology. XXIII. The angiotensisn II receptors
129. Facilitatory beta2-adrenoceptors on cholinergic and adrenergic nerve endings of the guinea pig trachea
130. 2+ mobilization in rat sympathetic neurons, but this signaling pathway does not mediate M-current inhibition
131. Noradrenaline storing vesicles in sympathetic neurons and their role in neurotransmitter release: An historical overview of controversial issues
132. Production and physiological actions of anandamide in the vasculature of the rat kidney
133. International Union of pharmacology. XII. Classification of opioid receptors
134. No effect of pertussis toxin on peripheral prejunctional alpha2-adrenoceptor-mediated responses and on endothelium-dependent relaxations in the rat
135. 3,4-Diaminopyridine masks the inhibition of noradrenaline release from chick sympathetic neurons via presynaptic α2-adrenoceptors: Insights into the role of N- and L-type calcium channels
136. 2+ and the release of noradrenaline evoked by the stimulation of presynaptic nicotinic receptors of chick sympathetic neurons in culture are not mediated via L-, N-, or P-type calcium channels
137. Presynaptic α2-adrenoceptors inhibit calcium influx in terminals of chicken sympathetic neurons and noradrenaline release evoked by nicotinic stimulation
138. BIBP 3226, suramin and prazosin identify neuropeptide Y, ATP and noradrenaline as sympathetic cotransmitters in the rat mesenteric bed
139. Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional beta-adrenoceptors: Evidence for the beta 2 subtype
140. Modulation of neural noradrenaline and ATP release by angiotensin II and prostaglandin E2 in guinea-pig vas deferens
141. Neural ATP release and its alpha 2-adrenoceptor-mediated modulation in guinea-pig vas deferens
142. P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens
143. Parasympathetic inhibition of pineal indole metabolism by prejunctional modulation of noradrenaline release
144. Presynaptic inhibition at the crayfish neuromuscular junction
145. Interactions of dynorphin A-(1-13) and nociceptin with cardiac D2 binding sites: Inhibition of ischemia-evoked release of noradrenaline from synaptosomal-mitochondrial fractions
146. Reduction of the pressor response to nicotine in the guinea pigs by a histamine (H3) agonist is attenuated by an inhibitor of nitric oxide synthesis
147. The chemical neuroanatomy of sympathetic ganglia
148. Effect of clenbuterol on the modulation of noradrenaline release in the rat tail artery
149. Histamine H3-receptor signaling in the heart: Possible involvement of Gi/Go proteins and N-type Ca++ channels
150. Development of the cholinergic neurotransmitter phenotype in postganglionic sympathetic neurons
151. ATP mediates fast synaptic transmission in mammalian neurons
152. P2X receptors in autonomic and sensory neurons
153. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins
154. The chemical transmitter at synapses in a sympathetic ganglion
155. Synaptotagmin I functions as a calcium regulator of release probability
156. Signaling functions and biochemical properties of pertussis toxin-resistant G-proteins
157. Desperately seeking subunits: Are native 5-HT3 receptors really homomeric complexes?
158. Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens
159. Interleukin-1 beta and tumor necrosis factor-alpha inhibit the release of [3H]-noradrenaline from mice isolated atria
160. Neuropeptide Y and pancreatic polypeptide reduce calcium currents in acutely dissociated neurons from adult rat superior cervical ganglia
161. Modulation of noradrenaline release by B1 and B2 kinin receptors during metabolic anoxia in the rat isolated atria
162. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats
163. Neuronal 5-HT receptors in the periphery
164. Neuropeptide Y Y1 receptors in vascular pharmacology
165. Presynaptic and postsynaptic inhibition of neurosynaptic reflex
166. How does adenosine inhibit transmitter release?
167. Effect of calcium channel blockers on norepinephrine release and modulation by D2 dopamine receptors
168. 2+ channels and D2 receptors
169. 2-adrenoceptors and D2 dopamine receptors on perivascular sympathetic nerves
170. Purinoceptor-mediated modulation by endogenous and exogenous agonists of stimulation-evoked [3H]noradrenaline release on rat iris
171. Heteroreceptor-mediated modulation of noradrenaline and acteylcholine release from peripheral nerves
172. ATP and endogenous agonists inhibit evoked [3H]-noradrenaline release in rat iris via A1 and P2y-like purinoceptors
173. Histamine and serotonin released from the rat perfused heart by compound 48/80 or by allergen challenge influence noradrenaline or acetylcholine exocytotic release
174. Effects of GABA on noradrenaline release and vasoconstriction induced by renal nerve stimulation in isolated perfused rat kidney
175. Autoregulation of neuromuscular transmission in the guinea pig saphenous artery
176. Tomosyn: A syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process
177. Subclassification of presynaptic alpha2-adrenoceptors: alpha2D-autoreceptors and alpha2D-adrenoceptors modulating release of acetylcholine in guinea pig ileum
178. Roles of peptides in transmission in the enteric nervous system
179. Synaptic functions in rat sympathetic neurons in microcultures I. Secretion of norepinephrine and acetylcholine
180. Chemical transmission between rat sympathetic neurons and cardiac myocytes developing in microcultures: Evidence for cholinergic, adrenergic, and dual function neurons
181. Existence of dopamine D1 receptor on the sympathetic nerve endings in the guinea-pig vas deferens
182. A search for presynaptic imidazoline receptors at rabbit and rat noradrenergic neurones in the absence of alpha 2-autoinhibition
183. ATP mediates fast synaptic potentials in enteric neurons
184. Insulin effects on the sympathetic contraction of rabbit ear arteries
185. Basal inhibitory action of endogenous endothelin on the sympathetic contraction in the isolated rat tail artery
186. Impaired potentiation by endothelin-1 and vasopressin of sympathetic contraction in tail artery from hypertensive rats
187. Effects of vasopressin on the sympathetic contraction of rabbit ear artery during cooling
188. Molecular determinants of presynaptic active zones
189. 2+-dependent binding of synaptotagmin to SNARE complexes
190. Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria
191. Nociceptin and neurotransmitter release in the periphery
192. 2+-induced and GTP analogue-induced catecholamine release from permeabilised adrenal chromaffin cells
193. Electrically evoked release of [3H]noradrenaline from mouse cultured sympathetic neurons: Release-modulating heteroreceptors
194. Calcium regulation of neurotransmitter release: Reliably unreliable?
195. Identification of histamine H3 receptors in the tail artery from normotensive and spontaneously hypertensive rats
196. Kinetic basis for the voltage-dependent inhibition of N-type calcium current by somatostatin and norepinephrine in chick sympathetic neurons
197. In vitro activation of cyclooxygenase in the rabbit carotid body: Effect of its blockade on [3H]catecholamine release
198. Opposite modulation of cotransmitter release in guinea-pig vas deferens: Increase of noradrenaline and decrease of ATP release by activation of prejunctional beta-adrenoceptors
199. Purinoceptor modulation of noradrenaline release in rat tail artery: Tonic modulation mediated by inhibitory P2Y and facilitatory A2A purinoceptors
200. Presynaptic imidazoline receptors. New developments in characterization and classification
201. Presynaptic 5-HT auto- and heteroreceptors in the human central and peripheral nervous system
202. Release of 3H-5-hydroxytryptamine from isolated rabbit aorta
203. Effect of inhibition of cyclooxygenase on pre- and postjunctional actions of peroxides in the iris-ciliary body
204. The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat
205. The isolation of nerve endings from brain: An electron-microscopic study of cell fragments derived by homogenization and centrifugation
206. Release of norepinephrine from neurons in dissociated cell cultures of chick sympathetic ganglia via stimulation of nicotinic and muscarinic acetylcholine receptors
207. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens
208. Prejunctional alpha2A-autoreceptors in the human gastric and ileocolic arteries
209. Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries
210. α-adrenoceptor-mediated prejunctional effects of chloroethylclonidine in the canine saphenous vein
211. The interactions of prostaglandins with the sympathetic nervous system: A review
212. Nicotine and sympathetic neurotranmission
213. Effects of A1-adenosine receptor antagonists on purinergic transmission in the guinea-pig vas deferens in vitro
214. Effects of agents that modulate intracellular cAMP levels on excitatory junction potentials recorded in the guinea-pig vas deferens in vitro
215. Alignment of receptor nomenclature with the human genome: Classification of 5-HT1B and 5-HT1D receptor subtypes
216. Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus
217. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts
218. Activation of histamine H3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia
219. Muscarinic inhibition of cardiac norepinephrine and NPY release during ischemia and reperfusion
220. Influence of imidazolines on catecholamine release in pithed spontaneously hypertensive rats
221. 2+-activated secretion
222. Resolution of regulated secretion into sequential MgATP-dependent and calcium-dependent stages mediated by distinct cytosolic proteins
223. Synaptic vesicle membrane fusion complex: Action of clostridial neurotoxins on assembly
224. Calcium dependence of the rate of exocytosis in a synaptic terminal
225. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission
226. Vasoactive intestinal peptide: Cardiovascular effects
227. Muscarinic inhibition of endogenous noradrenaline release from rabbit isolated trachea: Receptor subtype and receptor reserve
228. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971
229. Involvement of pertussis toxin-sensitive and -insensitive mechanisms in α-adrenoceptor modulation of noradrenaline release from rat sympathetic neurons in tissue culture
230. International Union of pharmacology. XIII. Classification of histamine receptors
231. Endocannabinoids and vascular function
232. Modulation of ion-channel function by G-protein-coupled receptors
233. Phosphorylation of synaptic vesicle proteins: Modulation of the alpha SNAP interaction with the core complex
234. 2+ channels in evoked release of norepinephrine from sympathetic neurons
235. Transmission at autonomic neuroeffector junctions
236. Transmission by postganglionic axons of the autonomic nervous system: The importance of the specialized neuroeffector junction
237. Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle
238. Identification of the platelet ADP receptor targeted by antithrombotic drugs
239. Characterization of the electrically evoked release of substance P from dorsal root ganglion neurons: Methods and dihydropyridine sensitivity
240. International Union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
241. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle
242. The mammalian brain rsec6/8 complex
243. 2+-dependent exocytosis in the somata of dorsal root ganglion neurons
244. 4-Aminopyridine-induced phasic contractions in rat caudal epididymis are mediated through release of noradrenaline
245. Prejunctionally mediated inhibition of neurotransmission by isoprenaline in rat vas deferens
246. How botulinum and tetanus neurotoxins block neurotransmitter release
247. Identification of opioid receptors in the sympathetic and parasympathetic nerves of guinea-pig atria
248. A post-docking role for synaptobrevin in synaptic vesicle fusion
249. 2+ channels in rat sympathetic neurones is mediated by guanine nucleotide binding proteins
250. Modulation of transmitter and hormone release by multiple neuronal opioid receptors
251. Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1-receptors and alpha2-adrenoceptors
252. Unmasking of activated histamine H3-receptors in myocardial ischemia: Their role as regulators of exocytotic norepinephrine release
253. Functional identification of histamine H3-receptors in the human heart
254. Lack of evidence for P2X-purinoceptor involvement in fast synaptic responses in intact sympathetic ganglia isolated from guinea-pigs
255. The influence of activation or inhibition of protein kinase C on the release of radioactivity from rat isolated atria labelled with [3H]-noradrenaline
256. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves
257. Methoxamine enhances the release of endogenous noradrenaline from rabbit ear artery: Possible involvement of ATP
258. Characterization of the facilitatory prejunctional purinoceptor on adrenergic nerves of the rabbit ear artery
259. Effect of 8-sulfophenyl theophylline on endogenous noradrenaline release from sympathetic nerves of the rabbit ear artery
260. Participation of cAMP in the facilitatory action of beta, gamma-methylene ATP on the noradrenaline release from rabbit ear artery
261. Effects of prostaglandin E1, and papaverine on non-neurogenic and neurogenic contraction of the isolated rabbit erectile tissue
262. Characteristics of function-specific pathways in the sympathetic nervous system
263. Prejunctional modulation by prostaglandin E2 of noradrenaline release from sympathetic neurones in rabbit aorta
264. Modulation of norepinephrine release from sympathetic neurons of the rabbit aorta by prejunctional prostanoid receptors
265. Prejunctional alpha 2-adrenoceptors and adenylyl cyclase regulation in the rabbit iris-ciliary body
266. M2-type muscarinic receptors mediate prejunctional inhibition of norepinephrine release in the human iris ciliary body
267. Regulation of intracellular chloride by cotransporters in developing lateral superior olive neurons
268. Presynaptic receptors and autonomic effectors
269. GABA suppresses stimulation-induced release of [3H]-noradrenaline from sympathetic nerve fibres in bovine ovarian follicles
270. Evidence for prejunctional GABAB receptors mediating inhibition of ovarian follicle contraction induced by nerve stimulation
271. Role of cyclic AMP in the release of noradrenaline from isolated rat atria. Effect of pretreatment with clenbuterol
272. State-dependent cross-inhibition between transmitter-gated cation channels
273. Role of calcium in neurotransmitter release evoked by alpha-latrotoxin or hypertonic sucrose
274. Effect of a selective NPY Y2 receptor antagonist on neuropeptide Y release
275. Priming in exocytosis: Attaining fusion-competence after vesicle docking
276. P2-receptor-mediated inhibition of noradrenaline release in the rat pancreas
277. Modulation by neurotransmitters of catecholamine secretion from sympathetic ganglion neurons detected by amperometry
278. GABAB receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat
279. Potentiation by adenosine of ATP-evoked dopamine release via a pertussis toxin-sensitive mechanism in rat phaeochromocytoma PC12 cells
280. Histamine H3 receptor activation inhibits sympathetic-cholinergic responses in cats
281. Modulation of submucosal arteriolar tone by neuropeptide Y receptors in the guinea pig small intestine
282. Mechanisms underlying ACh induced modulation of neurogenic and applied ATP constrictions in the guinea pig small intestine
283. Modulation of spontaneous and stimulation-evoked transmitter release from rat sympathetic neurons by the cognition enhancer linopirdine: Insights into its mechanisms of action
284. Somatic and prejunctional nicotinic receptors in cultured rat sympathetic neurones show different agonist profiles
285. The inhibitory glycine receptor: Architecture, synaptic localization and molecular pathology of a postsynaptlc ion-channel complex
286. Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: Contribution of P1- and P2-purinoceptors
287. Bradykinin B2 receptor-mediated stimulation of exocytotic noradrenaline release from cardiac sympathetic neurons
288. Presynaptic modulation by L-glutamate and GABA of sympathetic co-transmission in rat isolated vas deferens
289. 2-adrenoceptor-mediated response
290. Dependence of prejunctional beta-adrenoceptor facilitation of neurotransmission on stimulus train length and agonist exposure time
291. 4 receptors in gastrointestinal and genitourinary smooth muscle
292. Target regulation of transmitter phenotype
293. Presynaptic regulation of catecholamine release
294. Presynaptic receptors and their role in the regulation of transmitter release
295. Presynaptic regulation of the release of catecholamines
296. 25 Years sinc the discovery of presynaptic receptors: Present knowledge and future perspectives
297. Syntaphilin a syntaxin-1 clamp that controls SNARE assembly
298. 2+ channels in rat sympathetic ganglion neurons
299. Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens
300. Effect of morphine on the nerve terminal impulse and transmitter release from sympathetic varicosities innervating the mouse vas deferens
301. Osteogenic protein-1 induces dentritic growth in rat sympathetic neurons
302. The D3 dopamine receptor: Neurobiology and potential clinical relevance
303. Calcium-dependent dissociation of synaptotagmin from synaptic SNARE complexes
304. Histamine H(3)-receptors a new frontier in myocardial ischemia
305. Modulation of ion channels by protein phosphorylation and dephosphorylation
306. Presynaptic imidazoline receptors and alpha 2-adrenoceptors in the human heart: Discrimination by clonidine and moxonidine
307. Subclassification of presynaptic alpha2-adrenoceptors: alpha2A autoreceptors in rabbit atria and kidney
308. Pharmacological characterization of presynaptic alpha2-autoreceptors in rat submaxillary gland and heart atrium
309. A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibres by nicotinic agents
310. α-Adrenergic inhibition of sympathetic transmitter release mediated by modulation of N-type calcium-channel gating
311. Histamine H3 receptor-mediated suppression of inhibitory synaptic transmission in the submucous plexus of guinea-pig small intestine
312. Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals
313. Über humorale übertragbarkeit der herznervenwirkung
314. Interaction between the inhibitory action of acetylcholine and the alpha-adrenoceptor autoinhibitory feedback system on release of [3H]-noradrenaline from rat atria and rabbit ear artery
315. Prejunctional muscarinic receptor modulation of noradrenaline release from sympathetic neurons in rabbit aorta
316. Assembly of SnarE core complexes prior to neurotransmitter release sets the readily releasable pool of synaptic vesicles
317. Guanylyl cyclases and signaling by cyclic GMP
318. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits
319. Inhibition of sympathetic neurotransmission via NEM-sensitive H3-receptors in the guinea pig vas deferens
320. Direct evidence for histamine H3 receptor-mediated inhibition of norepinephrine release from sympathetic terminals of guinea pig myocardium
321. Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens
322. Presynaptic ionotropic receptors and the control of transmitter release
323. 2-Adrenoceptors: More subtypes but fewer functional differences
324. NPY Y2 receptor agonist, N-acetyl[Leu28, Leu31]NPY 24-36, inhibits renal vasoconstrictor activity in anaesthetised dogs
325. Inhibition of sympathetic cholinergic vasodilatation by a selective NPY Y2 receptor agonist in the gracilis muscle of anaesthetised dogs
326. Noradrenaline release and the effect of endogenous activation of the phospholipase C/protein kinase C signaling pathway in rat atria
327. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene
328. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat
329. EP3 receptor-mediated inhibition of the neurogenic vasopressor response in pithed rats
330. Histamine H3 receptors: General characterization and their function in the cardiovascular system
331. Nociceptin inhibits the neurogenic vasopressor response in the pithed rat via prejunctional ORL1 receptors
332. In vivo evidence that andogenous dopamine modulates sympathetic activity in man
333. 1 receptors for kinins
334. Potassium currents contributing to action potential repolarization in dissociated cultured rat superior cervical sympathetic neurones
335. Histamine modulation of neurotransmission in the sympathetic nervous system
336. 2-adrenoceptors
337. 2+-activated exocytosis in a cell-free system
338. Interaction of SNARE complexes with P/Q-type calcium channels in rat cerebellar synaptosomes
339. Norepinephrine release and ventricular fibrillation in myocardial ischemia/reperfusion: Roles of angiotensin and bradykinin
340. Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle
341. Inhibitory effects of endothelin-3 on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs
342. A receptor
343. Neurotransmitter release
344. Pituitary adenylate cyclase-activating polypeptide (PACAP) regulation of sympathetic neuron neuropeptide Y and catecholamine expression
345. Evoked noradrenaline release in the rabbit ear artery: Enhancement by purines, attenuation by NPY and lack of effect of calcitonin gene-related peptide
346. Somatostatin modulates vascular sympathetic neurotransmission in the rabbit ear artery
347. Histamine H3-receptor stimulation is unable to modulate noradrenaline release by the isolated rat heart during ischaemia-reperfusion
348. In vivo demonstration of H3-histaminergic inhibition of cardiac sympathetic stimulation by R-alpha-methyl-histamine and its prodrug BP 2.94 in the dog
349. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
350. Simultaneous measurement of [3H]noradrenaline release and neurogenic contraction under identical conditions, to determine the prejunctional inhibitory effects of SKF 99101H and BRL 56905 in dog saphenous vein
351. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
352. Presynaptic receptors
353. Inhibitory effect of GABA on cerebrovascular sympathetic neurotransmission
354. Pre- and post-junctional effects of adenosine triphosphate on noradrenergic transmission in the rabbit ear artery
355. Myosin II is involved in transmitter release at synapses formed between rat sympathetic neurons in culture
356. 2+ channels
357. Prejunctional regulation of reserpine-resistant sympathetic vasoconstriction and release of neuropeptide Y in the pig
358. Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors
359. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium
360. Mutual interaction between presynaptic alpha 2-adrenoceptors and 5-HT1B receptors on the sympathetic nerve terminals of the rat inferior vena cava
361. Subtype determination of presynaptic alpha 2-autoreceptors in the rabbit pulmonary artery and human saphenous vein
362. Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites
363. Presynaptic imidazoline receptors mediate inhibition of noradrenaline release from sympathetic nerves in rat blood vessels
364. Modulation of noradrenaline release from the sympathetic nerves of human right atrial appendages by presynaptic EP3- and DP-receptors
365. Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship
366. N-Type calcium channels control sympathetic neurotransmission in human heart atrium
367. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues
368. Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein by presynaptic histamine H3 receptors
369. Histamine, a neuromodulator of noradrenergic transmission in uterine horns from mice in diestrus
370. Presynaptic dopamine receptors involved in the inhibition of noradrenaline and dopamine release in the human gastric and uterine arteries
371. Lack of interaction between alpha(2)-autoreceptors and prejunctional receptors mediating a facilitatory effect on noradrenaline release
372. Prejunctional effects of angiotensin II and bradykinin in the heart and blood vessels
373. Involvement of angiotensin II receptors in the facilitatory effect of bradykinin on noradrenaline release from the rat left ventricle
374. Paired pulse analysis of ATP and noradrenaline release from sympathetic nerves of rat tail artery and mouse vas deferens: Effects of K+ channel blockers
375. Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia
376. Prejunctional alpha 2-adrenoceptors in mouse atria function through G-proteins which are sensitive to N-ethylmaleimide, but not pertussis toxin
377. 2-adrenoceptor-mediated inhibition of noradrenaline release from rat kidney cortex
378. Pertussis toxin does not attenuate alpha 2-adrenoceptor mediated inhibition of noradrenaline release in mouse atria
379. Evidence that angiotensin II enhances noradrenaline release from sympathetic nerves in mouse atria by activating protein kinase C
380. Effect of phorbol esters and polymyxin B on modulation of noradrenaline release in mouse atria
381. Frequency dependent alpha(2)-adrenoceptor mediated modulation of excitatory junction potentials in guinea-pig mesenteric artery
382. Modulatory effects of endothelin-1 on purinergic and adrenergic components of sympathetically-mediated contractile activity of rabbit saphenous artery
383. Endothelin-3 can both facilitate and inhibit transmitter release in the guinea-pig vas deferens
384. Inhibitory and facilitatory presynaptic effects of endothelin on sympathetic cotransmission in the rat isolated tail artery
385. Modulatory effects of type-C natriuretic peptide on sympathetic contransmission in the rat isolated tail artery
386. Effects of natriuretic peptides and endothelins on the nerve evoked release of adenine nucleotides and nucleosides in guinea pig vas deferens
387. Effects of adenosine on norepinephrine and acetylcholine release from guinea pig right atrium: Role of A1-receptors
388. ATP-activated current and its interaction with acetylcholine-activated current in rat sympathetic neurons
389. ATP- and acetylcholine-activated channels co-existing in cell-free membrane patches from rat sympathetic neuron
390. Hypoxia-induced release of prostaglandins: Mechanisms and sources of production in coronary resistance vessels of the isolated rabbit heart
391. Prostanoid receptors: Structures, properties, and functions
392. Effects of the antihypertensive agent, cicletanine, on noradrenaline release and vasoconstriction in perfused mesenteric artery of SHR
393. Effect of omega-conotoxin GVIA on noradrenaline release from postganglionic sympathetic neurones in rabbit aorta
394. Heterotrimeric G proteins: Organizers of transmembrane signals
395. Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells
396. Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites
397. 3 receptors form stable trimers: A novel structural motif of ligand-gated ion channels
398. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation
399. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system
400. Stimulation of mouse cultured sympathetic neurons by uracil but not adenine nucleotides
401. Pertussis toxin effects on transmitter release from perivascular nerve terminals
402. Individual sympathetic varicosities possess different sensitivities to alpha 2 and P2 receptor agonists and antagonists in mouse vas deferens
403. Neuropeptide Y inhibits adrenergic transmitter release in cultured rat superior cervical ganglion neurons by restricting the availability of calcium through a pertussis toxin-sensitive mechanism
404. Ocular actions of moxonidine: A possible role for imidazoline receptors
405. Evidence for cholinergic synapses between dissociated rat sympathetic neurons in cell culture
406. Enhancement by exogenous and locally generated angiotensin II of purinergic neurotransmission via angiotensin type 1 receptor in the guinea-pig isolated mesenteric artery
407. Species orthologs of the alspha-2A adrenergic receptor: The pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors
408. 2+ current
409. Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging
410. Prejunctional alpha2-autoreceptors in the canine saphenous vein
411. The elusive family of imidazoline binding sites
412. Presynaptic control of noradrenaline release from sympathetic nerves in human dental pulp
413. Inhibitory effects of adrenaline on the release of noradrenaline from sympathetic nerves in human dental pulp
414. Modulation by presynaptic beta-adrenoceptors of noradrenaline release from sympathetic nerves in human dental pulp
415. Evidence for presynaptic cholinergic receptors in sympathetic nerves in human dental pulp
416. Atrial natriuretic peptide regulation of noradrenaline release in the anterior hypothalamic area of spontaneously hypertensive rats
417. Protease resistance of syntaxin. SNAP-25. VAMP complexes. Implications for assembly and structure
418. Presynaptic histamine H2 receptors modulate the sympathetic nerve transmission in the isolated rat vas deferens: No role for H3-receptors
419. Endothelin receptors and calcium signaling
420. Functional evaluation of 5-hydroxytryptamine receptor activity in rat resistance vessels
421. + channels by lanthanum contributes to the block of transmitter release in chick and rat sympathetic neurons
422. 2+ and modulation of [3H]noradrenaline release in chick sympathetic neurons
423. 2+ in cultured sympathetic neurons
424. 2+]i and transmitter release in sympathetic neurons
425. The delta-opioid receptor: Molecular pharmacology, signal transduction, and the determination of drug efficacy
426. Modulation of noradrenaline release in rat isolated stomach by prostanoids, but not by histaminergic mechanisms
427. Receptors for purines and pyrimidines
428. Blockade of alpha 2-adrenoceptors permits the operation of otherwise silent opioid kappa-receptors at the sympathetic axons of rabbit jejunal arteries
429. 2--dependent neurotransmitter release
430. Oxotremorine-M activates single nicotinic acetylcholine receptor channels in cultured Xenopus myocytes
431. The motor nerve terminal as the primary focus for drug-induced facilitation of neuromuscular transmission
432. Role of N- and L-type calcium channels in depolarization-induced activation of tyrosine hydroxylase and release of norepinephrine by sympathetic cell bodies and nerve terminals
433. Calcium flux through predominantly independent purinergic ATP and nicotinic receptors
434. Developing neonatal rat sympathetic and sensory neurons differ in their regulation of 5-HT3 receptor expression
435. Presynaptic effects of gamma-aminobutyric acid on norepinephrine release and uptake in rat pineal gland
436. Effect of somatostatin on resistance and on capacitance rabbit isolated arteries
437. + channels in adult rat sympathetic neurons
438. Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium
439. Alpha2C- adrenoceptor-modulated release of noradrenaline in human right atrium
440. Beta 2-adrenergic, angiotensin II, and bradykinin receptors enhance neurotransmission in human kidney
441. Dopaminergic and alpha-adrenergic control of neurotransmission in human right atrium
442. Activation of beta 2-adrenoceptors by isoprenaline and adrenaline enhances noradrenaline release in cortical kidney slices of young spontaneously hypertensive rats
443. Beta 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria
444. Activation of alpha 1- and alpha 2-adrenoceptors inhibits noradrenaline release in rabbit renal arteries: Effects of pertussis toxin and N-ethylmaleimide
445. Himbacine discriminates between putative muscarinic M1 receptor-mediated responses
446. Lack of uptake, release and action of UTP at sympathetic perivascular nerve terminals in rabbit ear artery
447. Cardiovascular effects from stimulation of 5-hydroxytryptamine receptors
448. Interactions between the presynaptic alpha2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones
449. B receptors in the pig retina, rat vena cava and pithed rat vasculature
450. Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs
451. Intracellular calcium dependence of transmitter release rates at a fast central synapse
452. Noradrenaline release in the rat vena cava is inhibited by gamma-aminobutyric acid via GABAB receptors but not affected by histamine
453. 2-adrenoceptor- and μ-opioid receptor-mediated inhibition of [3H]noradrenaline release from rat brain cortical slices
454. 2+ current in rat sympathetic neurons via a G-protein
455. Activation of α-2 adrenergic receptors inhibits norepinephrine release by a pertussis toxin-insensitive pathway independent of changes in cytosolic calcium in cultured rat sympathetic neurons
456. Mechanism of neurotransmitter release elicited by the preferential alpha1-adrenergic receptor agonist phenylephrine in superfused superior cervical ganglion cells in culture
457. Cyclic AMP modulates but does not mediate the inhibition of [3H]norepinephrine release by activation of alpha-2 adrenergic receptors in cultured rat ganglion cells
458. Advances in understanding neuronal somatostatin receptors
459. Role of N-type calcium channels in autonomic neurotransmission in guinea-pig isolated left atria
460. Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: Novel mechanisms of ischemic norepinephrine release
461. Bradykinin B2 receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms
462. Substance P and somatostatin inhibit calcium channels in rat sympathetic neurons via different G protein pathways
463. 2+ channels by using knockout mice
464. Angiotensin II inhibits calcium and M current channels in rat sympathetic neurons via G proteins
465. 2+ channel modulation
466. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan
467. Phosphorylation of 25-kDa synaptosome-associated protein. Possible involvement in protein kinase C-mediated regulation of neurotransmitter release
468. Characterisation of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery
469. Effects of α,β-methylene ATP on the prejunctional purinoceptors of the sympathetic nerves of the rat caudal artery
470. In vitro studies of release of adenine nucleotides and adenosine from rat vascular endothelium in response to alpha 1-adrenoceptor stimulation
471. Effect of methoxamine on noradrenaline release in the caudal artery of hypertensive rats
472. Characterization of prejunctional purinoceptors inhibiting noradrenahne release in rat mesenteric arteries
473. Activation of protein kinase C potentiates norepinephrine release from sinus node
474. Effects of des-Asp-angiotensin I on the electrically stimulated contraction of the rabbit pulmonary artery
475. Presynaptic and postsynaptic effects of neuropeptide Y in the rat pineal gland
476. Omega-conotoxin GVIA-resistant neurotransmitter release in postganglionic sympathetic nerve terminals
477. Multiple calcium channels control neurotransmitter release from rat postganglionic sympathetic nerve terminals
478. Omega-conotoxin-resistant neurotransmitter release from postganglionic sympathetic nerves in the guinea pig vas deferens: Modulation by presynaptic receptors
479. 2+ activation of protein kinase C
480. 2+ acts by two separate pathways to modulate the supply of release-competent vesicles in chromaffin cells
481. Investigations of prejunctional alpha2-adrenoceptors in rat atrium, vas deferens and submandibular gland
482. Effects of a selective neuropeptide Y Y2 receptor antagonist on Y2 receptors at peripheral neuroeffector junctions
483. Electrophysiology of autonomic neuromuscular transmission involving ATP
484. Purinergic contransmission: Sympathetic nerves
485. Effect of aging on A1-adenosine receptor-mediated inhibition of norepinephrine release in the rat heart
486. Inhibition by the putative potassium channel opener pinacidil of the electrically-evoked release of endogenous dopamine and noradrenaline in the rat vas deferens
487. M1 muscrinic receptor-induced facilitation of ACh and noradrenaline release in the rat bladder is mediated by protein kinase C
488. Frequency dependence of muscarinic facilitation of transmitter release in urinary bladder strips from neurally intact or chronic spinal cord transacted rats
489. 3H]noradrenaline release from the isolated guinea pig right atrium by P2X receptors located on axon terminals
490. Effect of presynaptic P2 receptor stimulation on transmitter release
491. Enhancement of the excitatory actions of GABA by barbiturates and benzodiazepines
492. Regulation of noradrenaline release by presynaptic receptor systems
493. Presynaptic receptors
494. Presynaptic α-autoreceptors
495. Modulation of neurotransmitter release by presynaptic autoreceptors
496. Interactions of angiotensin, phenoxybenzamine and propranolol on noradrenaline release during sympathetic nerve stimulation
497. ATP release and its prejunctional modulation
498. Gamma-aminobutyric acid and postganglionic sympathetic transmission in the pulmonary artery of the rabbit
499. SnarE proteins contribute to calcium cooperativity of synaptic transmission
500. Basic mechanisms and local modulation of nerve impulse-induced secretion of neurotransmitters from individual sympathetic nerve varicosities
501. Do sympathetic nerves release noradrenaline in "quanta"?
502. Relative pre- and postjunctional roles of noradrenaline and ATP as neurotransmitters of the sympathetic nerves of guinea-pig and mouse vas deferens
503. Spatio-temporal pattern of quantal release of ATP and noradrenaline from sympathetic nerves: Consequences for neuromuscular transmission
504. Presynaptic P2 receptors?
505. Prejunctional modulation by angiotensins of noradrenaline release from sympathetic neurons in isolated rabbit aorta
506. Angiotensin II AT1 receptors in rat superior cervical ganglia: Characterization and stimulation of phosphoinositide hydrolysis
507. Calcium influx-independent depression of transmitter release by 5-HT at lamprey spinal cord synapses
508. Vasoactive intestinal polypeptide presynaptically enhances the synaptic transmission in cultured sympathetic neurons
509. The mechanisms of enhancement and inhibition of field stimulation responses of guinea-pig vas deferens by prostacyclin analogues
510. Modulation of nicotinic AChR channels by prostaglandin E2 in chick sympathetic ganglion neurons
511. Chronotropic and inotropic effects of histamine in developing chick heart: Differential mechanisms before and after hatching
512. Inotropic effects of histamine on developing chick heart: Release of transmitters from autonomic nerve terminals
513. Significant role of neuronal non-N-type calcium channels in the sympathetic neurogenic contraction of rat mesenteric artery
514. High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models
515. Influence of 5-hydroxytryptamine on the pressor responses induced by norepinephrine and electrical sympathetic stimulation in the pithed rat
516. Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves
517. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation
518. Differential cotransmission in sympathetic nerves: Role of frequency of stimulation and prejunctional autoreceptors
519. SnarE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis
520. ATP release evoked by isoprenaline from adrenergic nerves of guinea pig atrium
521. Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals
522. C-type natriuretic peptide neuromodulates independently of guanylyl cyclase activation
523. Adenosine receptor antagonism attenuates angiotensin II effects on adrenergic neurotransmission in the rabbit isolated vas deferens
524. Noradrenaline release from mouse postganglionic sympathetic neurons: Autoreceptor-mediated modulation
525. Modulatian of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues
526. Mouse postganglionic sympathetic neurons: Primary culturing and noradrenaline release
527. Occurrence, pharmacology and function of presynaptic alpha2-autoreceptors in alpha2A/D-adrenoceptor-deficient mice
528. A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice
529. α2-Adrenergic receptors of the α2C subtype mediating inhibition of norepinephrine release in human kidney cortex
530. Subclassification of presynaptic alpha 2-adrenoceptors: Alpha 2D-autoreceptors in guinea-pig atria and brain
531. Alpha2-adrenoceptor-mediated inhibition of cultured sympathetic neurons: Changes in alpha2A/D-adrenoceptor deficient mice
532. A re-investigation of questionable subclassifications of presynaptic alpha2-autoreceptors: Rat vena cava, rat atria, human kidney and guinea-pig urethra
533. Peptide modulation of ACh receptor desensitization controls neurotransmitter release from chicken sympathetic neurons
534. Local modulation of adrenergic neuroeffector interaction in the blood vessel well
535. Modulation of sympathetic outflow by centrally acting antihypertensive drugs
536. 2+ currents in PC12 cells
537. Utp evokes noradrenaline release from rat sympathetic neurons by activation of protein kinase C
538. Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions
539. The regulation of neurotransmitter secretion by protein kinase C
540. The role of endocardium in the facilitatory effect of bradykinin on electrically induced release of noradrenaline in rat cardiac ventricle
541. Adenosine and the endothelium-dependent modulation of 3H-noradrenaline release in the canine pulmonary artery
542. Presynaptic modulation of neurochemical transmission
543. Presynaptic modulation of cholinergic and noradrenergic neurotransmission: Interaction between them
544. Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: Support for neurotransmitter role of ATP
545. Receptor and carrier-mediated release of ATP of postsynaptic transmission: Cascade transmission
546. Stimulation-induced release of norepinephrine from rat superior cervical ganglia in vitro
547. Modulation of neural ATP release through presynaptic receptors
548. Co-release of noradrenaline and ATP from cultured sympathetic neurons
549. 2-purinoceptors in feedback control of sympathetic transmitter release
550. P2 purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens
551. Differences in the mode of stimulation of cultured rat sympathetic neurons between ATP and UTP
552. P2-receptors controlling neurotransmitter release from postganglionic sympathetic neurones
553. Role of action potentials and calcium influx in ATP- and UTP-induced noradrenaline release from rat cultured sympathetic neurons
554. Inhibition by nucleotides acting at presynaptic P2 receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens
555. Noradrenaline-ATP co-transmission in the sympathetic nervous system
556. P2-purinoceptor-mediated inhibition of noradrenalin release in rat atria
557. Stimulation of secretion in permeabilized PC 12 cells by adenosine 5′-[gamma-thio]triphosphate: Possible involvement of nucleoside diphosphate kinase
558. Presynaptic alpha 2-autoreceptors in mouse heart atria: Evidence for the alpha 2D subtype
559. Phorbol ester, an activator of protein kinase C, enhances calcium-dependent release of sympathetic neurotransmitter
560. Comparison of transmitter release properties of embryonic sympathetic neurons growing in vivo and in vitro
561. Demonstration of adrenergic and dopaminergic receptors in cultured sympathetic neurons: Their coupling to cAMP but not to the transmitter release process
562. Depolarizing stimuli and neurotransmitters utilize separate pathways to activate protein kinase C in sympathetic neurons
563. 3H]norepinephrine release
564. Biochemical machinery involved in the release of ATP from sympathetic nerve terminals
565. Role of N-, P- and Q-type voltage-gated calcium channels in transmitter release from sympathetic neurones in the mouse isolated vas deferens
566. β-Adrenoceptors modulate noradrenaline release from axonal sprouts in cultured rat superior cervical ganglia
567. Acetylcholine at motor nerves: Storage, release, and presynaptic modulation by autoreceptors and adrenoceptors
568. Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors
569. Local regulation of adrenergic neurotransmission
570. Hemodynamic actions of systemically injected pituitary adenylate cyclase activating polypeptide-27 in the rat
571. Thirty years of synaptosome research
572. Temporally resolved catecholamine spikes corresponding to single vesicle release from individual chromaffin cells
573. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system
574. Presynaptic nicotinic ACh receptors
575. Presynaptic inhibition of elicited neurotransmitter release
576. Inhibition of SNARE complex assembly differentially affects kinetic components of exocytosis
577. PACAP enhances stimulation-induced norepinephrine release in canine pancreas in vivo
578. Platelets increase the tone of quiescent rat aortic rings by release of serotonin and potentiate the subsequent contractile response to norepinephrine
579. 5-HT3 receptor channels in dissociated rat superior cervical ganglion neurons
580. Involvement of cGMP-dependent protein kinase in adrenergic potentiation of transmitter release from the calyx-type presynaptic terminal
581. Cholinergic M2 muscarinic receptor-mediated inhibition of endogenous noradrenaline release from the isolated vascularly perfused rat stomach
582. Characterization of nicotinic acetylcholine receptor-mediated noradrenaline release from the isolated rat stomach
583. Exocytotic release from neuronal cell bodies, dendrites and nerve terminals in sympathetic ganglia of the rat, and its differential regulation
584. Modulation of voltage-dependent calcium channels by G proteins
585. Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens
586. Pre- and postjunctional modulation by endothelin-1 of the adrenergic neurogenic response in canine mesenteric arteries
587. Prejunctional regulation by endogenous and exogenous acetylcholine of adrenergic nerve function in isolated canine mesenteric arteries
588. Patch-clamp analysis of glycine-induced currents in chick ciliary ganglion neurons
589. A sequential view of neurotransmitter release
590. Amperometric detection of stimulus-induced quantal release of catecholamines from cultured superior cervical ganglion neurons
591. 2+ channels in adult rat sympathetic neurons
592. 2+ channels of sympathetic neurons via a pertussis toxin-insensitive but cholera toxin-sensitive pathway
593. 2+ currents by various G protein-coupled receptors in sympathetic neurons of male rat pelvic ganglia
594. An electrophysiological study of the actions of angiotensin II at the sympathetic neuroeffector junction in the guinea-pig vas deferens